Glycemic Efficacy and Renal Safety Study of Dapagliflozin in Subjects With Type 2 Diabetes Mellitus and Moderate Renal Impairment
Public ClinicalTrials.gov record NCT00663260. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Double-Blind, Placebo-Controlled, Parallel Group, Randomized, Phase 2/3 Trial to Evaluate the Glycemic Efficacy, Renal Safety, Pharmacokinetics, and Pharmacodynamics of Dapagliflozin in Subjects With Type 2 Diabetes Mellitus and Moderate Renal Impairment Who Have Inadequate Glycemic Control
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine whether dapagliflozin is effective in the treatment of type 2 diabetes in subjects with poor blood sugar control and moderate renal impairment
Study identification
- NCT ID
- NCT00663260
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Enrollment
- 631 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 2008 (Type not available)
- Primary completion
- Dec 2009 (Actual)
- Completion
- Jun 2011 (Actual)
- Last update posted
- Feb 10, 2017
2008 – 2011
United States locations
- U.S. sites
- 34
- U.S. states
- 19
- U.S. cities
- 32
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Vista Medical Research, Inc. | Mesa | Arizona | 85206 | — |
| Valley Research | Fresno | California | 93720 | — |
| Marin Endocrine Care & Research, Inc. | Greenbrae | California | 94904 | — |
| Office Of Richard Cherlin, Md | Los Gatos | California | 95032 | — |
| Diabetes Medical Center Of California | Northridge | California | 91325 | — |
| Apex Research Of Riverside | Riverside | California | 92505 | — |
| La Biomed At Harbor Ucla Med Ctr. | Torrance | California | 90502 | — |
| Endocrine Associates Of The Rockies | Denver | Colorado | 80220 | — |
| Panhandle Family Care Associates | Marianna | Florida | 32446 | — |
| Genesis Clinical Research | Tampa | Florida | 33614 | — |
| Endocrine Research Solutions, Inc. | Roswell | Georgia | 30076 | — |
| Twin Cities Clinical Research | Brooklyn Center | Minnesota | 55430 | — |
| Kcva Medical Center Research Svc (151) | Kansas City | Missouri | 64128 | — |
| Va Nebraska-Western Iowa Health Care System (Nwihcs) | Omaha | Nebraska | 68105 | — |
| University Of Medicine And Dentistry Of New Jersey | Voorhees Township | New Jersey | 08043 | — |
| Winthrop University Hospital | Mineola | New York | 11501 | — |
| Slocum-Dickson Medical Group, Pllc | New Hartford | New York | 13413 | — |
| Community Health Care Of Manchester | Akron | Ohio | 44319 | — |
| Center For Thyroid Diseases And Endocrinology | Beachwood | Ohio | 44122 | — |
| Physician Research, Inc. | Zanesville | Ohio | 43701 | — |
| Univ Of Oklahoma Health Science Center | Oklahoma City | Oklahoma | 73104 | — |
| Rogue Valley Clinical Research | Medford | Oregon | 97504 | — |
| Drexel University College Of Medicine | Philadelphia | Pennsylvania | 19102 | — |
| Thomas Jefferson University | Philadelphia | Pennsylvania | 19107 | — |
| Low Country Internal Medicine Of Sc, Pa | Charleston | South Carolina | 29406 | — |
| Carolina Health Specialists | Myrtle Beach | South Carolina | 29572 | — |
| Palmetto Clinical Research | Summerville | South Carolina | 29485 | — |
| Research Institute Of Dallas | Dallas | Texas | 75231 | — |
| Westbury Medical Clinic P.A. | Houston | Texas | 77005 | — |
| The Strelitz Diabetes Center | Norfolk | Virginia | 23510 | — |
| Capital Clinical Research Center | Olympia | Washington | 98502 | — |
| Cedar Research Llc | Tacoma | Washington | 98405 | — |
| Aurora Advanced Healthcare | Milwaukee | Wisconsin | 53209 | — |
| Zablocki Veterans Affairs Medical Center | Milwaukee | Wisconsin | 53295 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 62 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00663260, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 10, 2017 · Synced Nov 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00663260 live on ClinicalTrials.gov.